I guess you have not seen my Ph.D in China specialties, obtained from the University of the interwebz.
And about the funding my livelihood, my -26.7% on ATM disagrees with you :D :D :D
Printable View
Good points, BP and therein lies the risks & opportunities when dealing with what is now unquestionably the biggest and fastest growing consumer market in the world - China.
https://www.statista.com/statistics/...-market-share/
Don’t let the facts stand in the way of what some of the posters here delude themselves on what’s really happening with the IF market in China!
A2M will continue to do well in the premium end of the market for a while yet while China’s domestic IF producers continue to move up the value chain. Watch for that inflection point!
Im picking a up day today after a way over sold beating that we have endured over the last week, great for D Ters IF you have the ba!!s to do so !
Not at all, couta1.
I am simply pointing out that China's domestic IF producers have been increasing their market share since 2016 - the dark days of the melamine scandal 15 years ago are not top of mind with the consumers there anymore. Top of mind is affordability and it is a fact that like ALL ASIANS, the Chinese prefer imported premium brands.
It is simply incorrect for some posters here to continue to rubbish China's IF producers as non-competitors now or in the future as the reason for A2M to continue to do well in that market.
A2M has an enviable premium position and the real issue here is how well it will maintain that position in the face of increased competition.
I went and had a look at A2 IF prices at our local supermarket the other day and it's interesting to note that the other brands (Karicare & Nestle) are selling 20% cheaper than A2M.
Meanwhile, stock is on my watch list but I am on the sidelines for 2 reasons:
1. Profit downgrades come in threes and that's still my major concern,
2. Insiders selling in the quantum that they did - not a good sign.
Fair enough?